Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
d-MAPPS Ophthalmic Solution
- Development stage
- Phase 3
- Lead developer
- Regenerative Ocular Immunobiologics
- Administration
- Ophthalmic, Topical
01
Overview
d-MAPPS Ophthalmic Solution is an investigational, platelet-derived biologic eye drop developed by Regenerative Ocular Immunobiologics LLC for the treatment of chronic ocular graft-versus-host disease (oGVHD). oGVHD is a severe inflammatory condition that occurs when donor immune cells attack the recipient's ocular tissues following a bone marrow or stem cell transplant. The drug is a sterile, preservative-free solution containing a complex mixture of platelet-derived growth factors and cytokines designed to reduce ocular surface inflammation and promote tissue repair. It is currently being evaluated in a Phase 3 pivotal clinical trial (NCT06852768) to assess its efficacy in improving ocular comfort and surface integrity in adult patients.
- Brand names
- d-MAPPS
- Other names
- d-MAPPS Ophthalmic Solution
02
Targets
IL1R1 (Interleukin-1 Receptor Type 1)TNFA (Tumor necrosis factor alpha (soluble))TRPV4 (Transient receptor potential cation channel subfamily V member 4)
Beyond the preview
Go deeper on d-MAPPS Ophthalmic Solution.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on d-MAPPS Ophthalmic Solution.